Genoa Ventures invests in early-stage companies innovating at the convergence of biology and technology.
Visionary startups developing innovative life science technologies with outsized potential often struggle to raise capital from traditional funders. These companies are typically multi-disciplinary (e.g. genomics + optics + microfluidics + big data) and/or market-making, and don't neatly fit most VC’s patterns and boxes.
People
- Jenny Rooke, Managing Director
You last contacted this investor on .